Medical/Pharmaceuticals
Tigermed Lauded by Frost & Sullivan for Its Rapid, Large-Scale Clinical Developmental Services
Tigermed's comprehensive service portfolio and robust infrastructure cement its status as a strategic partner for the pharmaceuticals industry LONDON, June 2, 2020 /PRNewswire/ -- Based on its recent analysis of the Chinese contract research organizations (CROs) market, Frost & Sullivan recogniz...
2020-06-02 22:00
6669
DERMALOG Fever Check at Clever Fit Gym
KALTENKIRCHEN and HAMBURG, Germany, June 2, 2020 /PRNewswire/ -- After a mandatory corona break of several weeks, sports facilities and fitness studios inGermany are reopening. Operators have to comply with numerous hygiene regulations to minimize infection risks for customers and employees. This...
2020-06-02 21:46
1885
Ajinomoto Bio-Pharma Services Completes Acquisition of Granules OmniChem Joint Venture in India
WETTEREN, Belgium, June 2, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce that it has completed the acquisition of Granules OmniChem Private Limited, purchasing ...
2020-06-02 20:04
2358
Seven Bridges Announces International Collaboration Focused on Personalized Treatment for Kids with Cancer
Expansion of the CAVATICA Platform to Australia Enables Harmonized Analysis of Geographically Separated and Jurisdictionally Protected Data Resources BOSTON, June 2, 2020 /PRNewswire/ -- Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced a collaborative partn...
2020-06-02 20:00
1761
Technopath Clinical Diagnostics Launches the First Not-For-Profit COVID-19 Antibody Testing Initiative to Support Companies in Ireland
BALLINA (County Tipperary), Ireland, June 2, 2020 /PRNewswire/ -- Technopath Clinical Diagnostics today announced that it is rolling out COVID-19 antibody testing inIreland to help businesses navigate a safer workplace re-entry. This initiative will provide key services to all industries and will...
2020-06-02 19:00
2885
QPS Awarded Two 2020 CRO Leadership Awards
NEWARK, Delaware, June 2, 2020 /PRNewswire/ -- QPS is a GLP/GCP-compliant and CLIA-certified contract research organization (CRO) delivering discovery, preclinical, and clinical drug development services since 1995. An award-winning leader focused on bioanalytics and clinical trials, QPS, has be...
2020-06-02 18:55
2812
PepsiCo Thailand Commits 18,000,000 Baht to Supporting COVID-19 Relief Efforts in Thailand
Ms. Wei Wei Yao, SVP & GM, Asia BU and China Beverages BU of Pepsi Cola (Thai) Trading Co., Ltd.BANGKOK, June 2, 2020 /PRNewswire/ -- PepsiCo Thailand, Suntory PepsiCo Beverages Thailand, and The PepsiCo Foundation have partnered with Raks Thai Foundation to reach the most vulnerable communities...
2020-06-02 18:09
5959
Cellenkos(R) Inc. Announces FDA Clearance to Initiate Phase 1 Double- Blinded, Randomized, Placebo-Controlled Trial of Cryopreserved Cord Blood-Derived T-Regulatory Cells (CK0802) for Treatment of COVID-19 Associated Acute Respiratory Distress Syndrome
HOUSTON, June 2, 2020 /PRNewswire/ -- Cellenkos Inc., a privately held, clinical stage biotech company announced today that the US Food & Drug Administration (FDA) has cleared the way to initiate a Phase 1 clinical trial of CK0802 (Cryopreserved Cord Blood Derived T-Regulatory Cells) for treatmen...
2020-06-02 18:00
1761
Lunit INSIGHT MMG, an AI Solution for Breast Cancer Detection, Now CE Certified
SEOUL, South Korea, June 2, 2020 /PRNewswire/ -- Lunit today announced that its AI solution for breast cancer, Lunit INSIGHT MMG, has been CE certified. The medical software was certified onMay 26th, making it now commercially available across the European Economic Area. The certified software, ...
2020-06-02 16:00
1446
icometrix launches its icompanion platform for people with multiple sclerosis
LEUVEN, Belgium and CHICAGO, June 2, 2020 /PRNewswire/ -- icometrix, the world leader to extract clinically meaningful data from brain scans, is proud to have launched the icompanion platform and phone application for people with multiple sclerosis on World MS Day! icompanion is a medical device...
2020-06-02 15:00
1704
Modular Bioscience Acquires Exclusive License to University of Illinois Urbana Champaign Artificial Restriction Enzyme Technology
SILICON VALLEY, Calif., June 2, 2020 /PRNewswire/ -- Modular Bioscience, an early stage biotechnology company based in Silicon Valley, today announced that it has executed a definitive agreement with theUniversity of Illinois at Urbana-Champaign for an exclusive global patent license to a novel a...
2020-06-02 13:28
1969
Adagio Medical Receives CE Mark Approval for its iCLAS(TM) Cryoablation System and Prepares for European Commercial Launch
LAGUNA HILLS, Calif., June 2, 2020 /PRNewswire/ -- Adagio Medical, Inc., announces that it has received CE Mark approval for its ultra-low temperaturei ntelligentContinuous Lesion Ablation System (iCLAS) for the endocardial treatment of paroxysmal (PAF) and persistent (PsAF) atrial fibrillation an...
2020-06-02 11:25
2008
icometrix launches its icompanion platform for people with multiple sclerosis
LEUVEN, Belgium and CHICAGO, June 2, 2020 /PRNewswire/ -- icometrix, the world leader to extract clinically meaningful data from brain scans, is proud to have launched the icompanion platform and phone application for people with multiple sclerosis on World MS Day! icompanion is a medical device...
2020-06-02 08:00
1906
Innovent Announced the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study
SUZHOU, China, June 2, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced the ...
2020-06-02 07:30
6150
AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings
AGC Biologics acquires Boulder, Colorado U.S.A. facility to increase global capacity and extend manufacturing scale SEATTLE, June 2, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the purchase of a state-of-the...
2020-06-02 06:00
3346
Cynosure Launches Elite iQ™ Aesthetic Workstation For Laser Hair Removal and Skin Revitalization in the United States, Europe and Australia
The World's First Alexandrite-ND: YAG System Now Upgraded with Skintel®, The Industry's Only Melanin Reader™ For More Customized Laser Hair Removal Treatments For All Skin Types WESTFORD, Massachusetts, June 1, 2020 /PRNewswire/ -- Cynosure announced today the U.S., European and Australian launc...
2020-06-01 20:45
2694
Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR®
SHANGHAI, June 1, 2020 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today held a special signing ceremony as part of the "We Care About Mental Health" initiative, marking the start of three new strategic partnerships across the region. As part of the initiative, Luye Pharma granted Alvogen Kor...
2020-06-01 15:22
7964
Henlius and Accord Receive Positive CHMP Opinion for Oncology Biosimilar, HLX02 (Trastuzumab)
SHANGHAI, June 1, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord) jointly announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing aut...
2020-06-01 13:48
3564
Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal
SYDNEY, June 1, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a poster presentation of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most comm...
2020-06-01 08:45
5124
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)
SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...
2020-06-01 07:30
1865
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7722
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7116